Trial Profile
A study on Pegasys or PegIFNα-2b plus Ribavirin in the treatment of non-responsive Chronic Hepatitis C patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2013
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 21 Aug 2013 New trial record